Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
StreetIQ was a financial technology company that provided a specialized platform for institutional investors to access corporate events, earnings call audio, and transcripts. While not a drug-developing biotechnology company, it served the life sciences and healthcare sectors by providing critical investor relations data and market intelligence for publicly traded pharmaceutical and biotech firms. The company's technology focused on streamlining corporate access and enhancing transparency for financial analysts covering the healthcare industry. StreetIQ was eventually acquired by Acuris (now part of ION Group) and integrated into its broader suite of financial and industry intelligence tools, including BioPharm Insight.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on StreetIQ.